Syndax Pharmaceuticals Inc
SNDX
14 insider filings · Latest: Jun 11, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 12, 2026 | Jun 12 9:09 PM | Nicholas A.J. BotwoodHead of R&D, CMO | Sale | 31,235 | $18.14 | $566.6K | 60,885(D) | View → |
| Jun 11, 2026 | Jun 12 9:09 PM | Nicholas A.J. BotwoodHead of R&D, CMO | Sale | 34,280 | $18.00 | $617.0K | 60,885(D) | View → |
| Jun 12, 2026 | Jun 12 8:10 PM | Botwood Nicholas A.J. | Proposed Sale | 31,235 | $18.14 | $566.7K | — | View → |
| Jun 11, 2026 | Jun 11 8:12 PM | Botwood Nicholas A.J. | Proposed Sale | 34,280 | $17.78 | $609.4K | — | View → |
| Jun 1, 2026 | Jun 2 8:30 PM | Keith A. GoldanChief Financial Officer | Sale | 1,177 | $18.99 | $22.4K | 139,252(D) | View → |
| Jun 1, 2026 | Jun 2 8:30 PM | Michael A MetzgerDirector, Chief Executive Officer | Sale | 6,847 | $18.99 | $130.0K | 484,843(D) | View → |
| Jun 1, 2026 | Jun 1 7:59 PM | Goldan Keith A. | Proposed Sale | 1,177 | $18.99 | $22.4K | — | View → |
| Jun 1, 2026 | Jun 1 7:54 PM | Metzger Michael A | Proposed Sale | 6,847 | $18.99 | $130.0K | — | View → |
| Feb 9, 2026 | Feb 10 2:00 PM | Michael A MetzgerDirector, Chief Executive Officer | Sale | 17,159 | $21.03 | $360.8K | 491,690(D) | View → |
| Feb 9, 2026 | Feb 10 1:59 PM | Keith A. GoldanChief Financial Officer | Sale | 3,410 | $21.03 | $71.7K | 140,429(D) | View → |
| Feb 9, 2026 | Feb 9 8:57 PM | Metzger Michael A | Proposed Sale | 17,159 | $21.03 | $360.8K | — | View → |
| Feb 9, 2026 | Feb 9 8:42 PM | Goldan Keith A. | Proposed Sale | 3,410 | $21.03 | $71.7K | — | View → |
| Feb 6, 2026 | Feb 6 10:54 PM | Michael A MetzgerDirector, Chief Executive Officer | Sale | 7,412 | $20.62 | $152.8K | 508,849(D) | View → |
| Feb 6, 2026 | Feb 6 10:53 PM | Keith A. GoldanChief Financial Officer | Sale | 2,082 | $20.62 | $42.9K | 143,839(D) | View → |
| Feb 6, 2026 | Feb 6 8:47 PM | Metzger Michael A | Proposed Sale | 7,412 | $20.62 | $152.8K | — | View → |
| Feb 6, 2026 | Feb 6 8:43 PM | Goldan Keith A. | Proposed Sale | 2,082 | $20.62 | $42.9K | — | View → |
| Sep 8, 2025 | Sep 8 8:25 PM | MICHAEL METZGER | Proposed Sale | 157,307 | $17.04 | $2.7M | — | View → |
| Aug 18, 2025 | Aug 18 8:36 PM | DENNIS G PODLESAK | Proposed Sale | 14,400 | $15.74 | $226.7K | — | View → |
| Aug 14, 2025 | Aug 14 8:26 PM | DENNIS G PODLESAK | Proposed Sale | 43,200 | $13.45 | $581.0K | — | View → |
| Jul 16, 2025 | Jul 16 7:29 PM | Goldan Keith A. | Proposed Sale | 1,296 | $9.29 | $12.0K | — | View → |
Page 1 of 2
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 12, 2026 | Jun 12 9:09 PM | Nicholas A.J. BotwoodHead of R&D, CMO | Option Exercise | 31,235 | $13.82 | 0(D) | View → |
| Jun 11, 2026 | Jun 12 9:09 PM | Nicholas A.J. BotwoodHead of R&D, CMO | Option Exercise | 22,515 | $13.82 | 0(D) | View → |
| Feb 4, 2026 | Feb 6 10:54 PM | Michael A MetzgerDirector, Chief Executive Officer | Grant/Award | 440,000 | $20.43 | 440,000(D) | View → |
| Feb 4, 2026 | Feb 6 10:53 PM | Keith A. GoldanChief Financial Officer | Grant/Award | 118,000 | $20.43 | 118,000(D) | View → |
| Feb 4, 2026 | Feb 6 9:50 PM | Nicholas A.J. BotwoodHead of R&D, CMO | Grant/Award | 144,700 | $20.43 | 144,700(D) | View → |